Indian Biopharmaceuticals Industry Report

Indian Biopharmaceuticals Industry Report

Indian biotechnology industry is advancing into new heights in tandem with the growth and progression observed globally. The past performance of the industry indicates that it has surpassed the growth rate of many other industries. India is counted among the top 12 global biotech hotspots and is the 3rd largest in Asia Pacific (in terms of number of biotech companies). The global biotech industry size is currently US$54 billion, whereas the Indian biotech industry just crossed the US$1.07 billion (Rs4,745 crore) mark in 2004-05. Bio Pharma remained the largest contributor to the sector with a value contribution of Rs. 3,570 crore accounting for a 75% contribution. Diagnostics, vaccines and recombinant therapeutic proteins are the three main segments in bio pharma industry.

The report on Indian Biopharmaceuticals Industry covers the industry size and its growth over the past few years. The segments of the industry along with growth drivers and the issues and challenges of the industry are briefed. The core technologies in the industry and the major players of the industry are also discussed with their profiles. The regulatory environment and the associated bodies are mentioned and the critical success factors in the industry are highlighted. This report also has the details on emerging trends in the industry and the opportunities for India and to end the report an outlook for the industry is also given. The report will be useful to the biotech industry and especially companies in biopharma, agri-biotechnology, industrial biotechnology, bio-services and bioinformatics in understanding this industry in a better way. It will also be useful to the government department and agencies working in the field of biotechnology to get an insight of the biopharma industry. The educational institutes may also use this information for their academic purpose to have in -depth industry knowledge. Other research bodies, industry experts, associations & consortia of the industry and consulting organizations may also benefit through the information given in the report.

The report has been prepared from numerous sources which include: Publication of the industry, industry interactions, websites, and proprietary and subscribed databases. Due diligence and adequate care has been taken in the report to check and validate the figures used.

Total number of pages: 208, Number of tables: 23, Number of charts: 20

Indian biotechnology industry is advancing into new heights in tandem with the growth and progression observed globally. The past performance of the industry indicates that it has surpassed the growth rate of many other industries. India is counted among the top 12 global biotech hotspots and is the 3rd largest in Asia Pacific (in terms of number of biotech companies). The global biotech industry size is currently US$54 billion, whereas the Indian biotech industry just crossed the US$1.07 billion (Rs4,745 crore) mark in 2004-05. Bio Pharma remained the largest contributor to the sector with a value contribution of Rs. 3,570 crore accounting for a 75% contribution. Diagnostics, vaccines and recombinant therapeutic proteins are the three main segments in bio pharma industry.

The report on Indian Biopharmaceuticals Industry covers the industry size and its growth over the past few years. The segments of the industry along with growth drivers and the issues and challenges of the industry are briefed. The core technologies in the industry and the major players of the industry are also discussed with their profiles. The regulatory environment and the associated bodies are mentioned and the critical success factors in the industry are highlighted. This report also has the details on emerging trends in the industry and the opportunities for India and to end the report an outlook for the industry is also given. The report will be useful to the biotech industry and especially companies in biopharma, agri-biotechnology, industrial biotechnology, bio-services and bioinformatics in understanding this industry in a better way. It will also be useful to the government department and agencies working in the field of biotechnology to get an insight of the biopharma industry. The educational institutes may also use this information for their academic purpose to have in -depth industry knowledge. Other research bodies, industry experts, associations & consortia of the industry and consulting organizations may also benefit through the information given in the report.

The report has been prepared from numerous sources which include: Publication of the industry, industry interactions, websites, and proprietary and subscribed databases. Due diligence and adequate care has been taken in the report to check and validate the figures used.

Total number of pages: 208, Number of tables: 23, Number of charts: 20